Literature DB >> 7557970

Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

K Kobayashi1, H Kakinoki, T Fukushige, N Shaheen, H Terazono, T Saheki.   

Abstract

Citrullinemia is an autosomal recessive disorder caused by a genetic deficiency of argininosuccinate synthetase (ASS). So far 20 mutations in ASS mRNA have been identified in human classical citrullinemia, including 14 single base changes causing missense mutations in the coding sequence of the enzyme, 4 mutations associated with an absence of exons 5, 6, 7, or 13 in mRNA, 1 mutation with a deletion of the first 7 bases in exon 16 (which is caused by abnormal splicing), and 1 mutation with an insertion of 37 bases between the exon 15 and 16 regions in mRNA. In order to identify the abnormality in the ASS gene causing the exon 7 and 13 deletion mutations and the 37-base insertion mutation between exons 15 and 16 in mRNA, and to establish a DNA diagnostic test, we isolated and sequenced the genomic DNA surrounding each exon. The absence of exon 7 or 13 in ASS mRNA resulted from abnormal splicing caused by a single base change in the intron region: IVS-6(-2) (a transition of A to G at the second nucleotide position within the 3' splice cleavage site of intron 6) and IVS-13(+5) (a transition of G to A at the fifth nucleotide position within the 5' splice cleavage site of intron 13), respectively. The IVS-6(-2) mutation resulted in the creation of an MspI restriction site. DNA diagnostic analysis of 33 Japanese alleles with classical citrullinemia showed that 19 alleles had the IVS-6(-2) mutation (over 50% of the mutated alleles in Japanese patients). It was thus confirmed that one mutation is predominant in Japan. This differs from the situation in the USA where there is far greater heterogeneity. The insertion mutation in mRNA on the other hand resulted from abnormal splicing caused by a 13-bp deletion at the splice-junction between exon 15 and intron 15. The deletion had a short direct repeat (CTCAGG) at the breakpoint junction and presumably resulted from slipped mispairing.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557970     DOI: 10.1007/bf00191806

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  38 in total

1.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

Review 2.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Sequence for human argininosuccinate synthetase cDNA.

Authors:  H G Bock; T S Su; W E O'Brien; A L Beaudet
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

4.  The structure and evolution of the human beta-globin gene family.

Authors:  A Efstratiadis; J W Posakony; T Maniatis; R M Lawn; C O'Connell; R A Spritz; J K DeRiel; B G Forget; S M Weissman; J L Slightom; A E Blechl; O Smithies; F E Baralle; C C Shoulders; N J Proudfoot
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene.

Authors:  R Kornreich; D F Bishop; R J Desnick
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

6.  Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia.

Authors:  K Kobayashi; M J Jackson; D B Tick; W E O'Brien; A L Beaudet
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

7.  A search for the primary abnormality in adult-onset type II citrullinemia.

Authors:  K Kobayashi; N Shaheen; R Kumashiro; K Tanikawa; W E O'Brien; A L Beaudet; T Saheki
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

8.  Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia.

Authors:  K Kobayashi; N Shaheen; H Terazono; T Saheki
Journal:  Am J Hum Genet       Date:  1994-12       Impact factor: 11.025

9.  Human chromosomal assignments for 14 argininosuccinate synthetase pseudogenes: cloned DNAs as reagents for cytogenetic analysis.

Authors:  T S Su; R L Nussbaum; S Airhart; D H Ledbetter; T Mohandas; W E O'Brien; A L Beaudet
Journal:  Am J Hum Genet       Date:  1984-09       Impact factor: 11.025

10.  Intron sequences involved in lariat formation during pre-mRNA splicing.

Authors:  R Reed; T Maniatis
Journal:  Cell       Date:  1985-05       Impact factor: 41.582

View more
  14 in total

1.  Hepatocellular carcinoma associated with adult-type citrullinemia.

Authors:  T Ito; K Shiraki; K Sekoguchi; T Yamanaka; K Sugimoto; K Takase; Y Tameda; T Nakano
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

2.  Two hypomorphic alleles of mouse Ass1 as a new animal model of citrullinemia type I and other hyperammonemic syndromes.

Authors:  Carlos J Perez; Jean Jaubert; Jean-Louis Guénet; Kirstin F Barnhart; Catherine M Ross-Inta; Vicente C Quintanilla; Isabelle Aubin; Jimi L Brandon; Nancy W Otto; John DiGiovanni; Irma Gimenez-Conti; Cecilia Giulivi; Donna F Kusewitt; Claudio J Conti; Fernando Benavides
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

3.  Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.

Authors:  T Yasuda; N Yamaguchi; K Kobayashi; I Nishi; H Horinouchi; M A Jalil; M X Li; M Ushikai; M Iijima; I Kondo; T Saheki
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

4.  Citrulline and ammonia accumulating in citrullinemia reduces antioxidant capacity of rat brain in vitro.

Authors:  Cristina C Prestes; Angela M Sgaravatti; Carolina D Pederzolli; Mirian B Sgarbi; Giovanni K Zorzi; Clóvis M D Wannmacher; Moacir Wajner; Angela T S Wyse; Carlos Severo Dutra Filho
Journal:  Metab Brain Dis       Date:  2006-04-27       Impact factor: 3.584

5.  Type II citrullinaemia (citrin deficiency) in a neonate with hypergalactosaemia detected by mass screening.

Authors:  E Naito; M Ito; S Matsuura; T Saijo; Y Ogawa; S Kitamura; K Kobayashi; T Saheki; Y Nishimura; N Sakura; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

6.  Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria.

Authors:  L Palmieri; B Pardo; F M Lasorsa; A del Arco; K Kobayashi; M Iijima; M J Runswick; J E Walker; T Saheki; J Satrústegui; F Palmieri
Journal:  EMBO J       Date:  2001-09-17       Impact factor: 11.598

Review 7.  Pathogenesis and pathophysiology of citrin (a mitochondrial aspartate glutamate carrier) deficiency.

Authors:  Takeyori Saheki; Keiko Kobayashi; Mikio Iijima; Ikumi Nishi; Tomotsugu Yasuda; Naoki Yamaguchi; Hong Zhi Gao; Md Abdul Jalil; Laila Begum; Meng Xian Li
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

8.  Evaluation of gene therapy for citrullinaemia using murine and bovine models.

Authors:  G Patejunas; B Lee; J A Dennis; P J Healy; P J Reeds; H Yu; M Frazer; B Mull; A W Warman; A L Beaudet; W E O'Brien
Journal:  J Inherit Metab Dis       Date:  1998       Impact factor: 4.982

9.  A novel inborn error of metabolism detected by elevated methionine and/or galactose in newborn screening: neonatal intrahepatic cholestasis caused by citrin deficiency.

Authors:  Toshihiro Ohura; Keiko Kobayashi; Daiki Abukawa; Yusaku Tazawa; Jun-ichiro Aikawa; Osamu Sakamoto; Takeyori Saheki; Kazuie Iinuma
Journal:  Eur J Pediatr       Date:  2003-02-27       Impact factor: 3.183

Review 10.  Contrasting features of urea cycle disorders in human patients and knockout mouse models.

Authors:  Joshua L Deignan; Stephen D Cederbaum; Wayne W Grody
Journal:  Mol Genet Metab       Date:  2007-10-22       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.